2025 Asia-Pacific Blood Testing Market Revenue Opportunities Report
Description
The 2025 Asia-Pacific Blood Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Asia-Pacific blood testing market are Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, and Siemens Healthineers. These companies lead with extensive portfolios covering glucose testing, molecular diagnostics, and blood collection devices, driving market growth in the region. Roche and Abbott are particularly prominent, supported by innovations in diagnostics and expansions across key Asia-Pacific countries such as China, India, and Japan. Bio-Rad and Siemens Healthineers are also significant players, leveraging advanced technologies and broad diagnostic solutions to meet rising demand for blood tests fueled by chronic diseases and increasing healthcare access.
These companies benefit from the Asia-Pacific region’s fastest-growing blood testing market, projected to reach upwards of USD 36.9 billion by 2030 with a CAGR above 9%. Major trends include increased investments in healthcare infrastructure, rising prevalence of diabetes and infectious diseases, and governmental initiatives improving diagnostic accessibility. Abbott and Roche have applied a focus on glucose and molecular diagnostic testing, while Bio-Rad and Siemens enhance blood collection device technology. Collectively, their presence, product innovation, and regional partnerships strengthen the diagnostic ecosystem, addressing the large patient pool and accelerating screening needs across urban and rural Asia-Pacific populations.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Asia-Pacific blood testing market are Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, and Siemens Healthineers. These companies lead with extensive portfolios covering glucose testing, molecular diagnostics, and blood collection devices, driving market growth in the region. Roche and Abbott are particularly prominent, supported by innovations in diagnostics and expansions across key Asia-Pacific countries such as China, India, and Japan. Bio-Rad and Siemens Healthineers are also significant players, leveraging advanced technologies and broad diagnostic solutions to meet rising demand for blood tests fueled by chronic diseases and increasing healthcare access.
These companies benefit from the Asia-Pacific region’s fastest-growing blood testing market, projected to reach upwards of USD 36.9 billion by 2030 with a CAGR above 9%. Major trends include increased investments in healthcare infrastructure, rising prevalence of diabetes and infectious diseases, and governmental initiatives improving diagnostic accessibility. Abbott and Roche have applied a focus on glucose and molecular diagnostic testing, while Bio-Rad and Siemens enhance blood collection device technology. Collectively, their presence, product innovation, and regional partnerships strengthen the diagnostic ecosystem, addressing the large patient pool and accelerating screening needs across urban and rural Asia-Pacific populations.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
